PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7734622-0	1995	cAMP and PMA enhance the effects of IGF-I in the proliferation of endometrial adenocarcinoma cell line HEC-1-A by acting at the G1 phase of the cell cycle.	Tetradecanoylphorbol Acetate	9-12	NDC80 kinetochore complex component	Homo sapiens	103-108	
9345355-1	1997	Previous studies from this laboratory have shown that epidermal growth factor (EGF) and the tumor promoter, phorbol myristate acetate (PMA), are mitogenic in the endometrial cancer cell line HEC-1-A.	Tetradecanoylphorbol Acetate	108-133	NDC80 kinetochore complex component	Homo sapiens	191-196	
8912814-5	1996	The moderately differentiated endometrial HEC-1-B adenocarcinoma cell line showed a marked increase in proliferative activity and a profound morphological change in response to TPA.	Tetradecanoylphorbol Acetate	177-180	NDC80 kinetochore complex component	Homo sapiens	42-47	
1280205-3	1992	The addition of 10(-7) M 4 beta-phorbol 12-myristate 13-acetate (PMA) to HEC-50 and HEC-1B cells resulted in changes in cell morphology, growth inhibition, activation of PKC, and an increase in expression of IGFBP-1.	Tetradecanoylphorbol Acetate	25-63	NDC80 kinetochore complex component	Homo sapiens	84-89	
1280205-3	1992	The addition of 10(-7) M 4 beta-phorbol 12-myristate 13-acetate (PMA) to HEC-50 and HEC-1B cells resulted in changes in cell morphology, growth inhibition, activation of PKC, and an increase in expression of IGFBP-1.	Tetradecanoylphorbol Acetate	65-68	NDC80 kinetochore complex component	Homo sapiens	84-89